Prevalence of asthma, aspirin intolerance, nasal polyposis and chronic obstructive pulmonary disease in a population-based study - PubMed (original) (raw)
Comparative Study
Prevalence of asthma, aspirin intolerance, nasal polyposis and chronic obstructive pulmonary disease in a population-based study
J Hedman et al. Int J Epidemiol. 1999 Aug.
Abstract
Background: Remarkable overlap exists in symptoms between asthma and chronic obstructive pulmonary disease (COPD), and the symptoms of the patients with mild asthma are often falsely thought to be caused by smoking. The objective of the study was to determine the prevalence of doctor-diagnosed asthma, asthmatic symptoms and doctor-diagnosed COPD in an adult population. The prevalence and relation to asthma of aspirin intolerance, nasal polyposis, allergic rhinitis and smoking habits were also examined.
Methods: Postal questionnaire survey of a population-based random sample (4300) of adult women and men aged 18-65 years served by the Päijät-Häme Central Hospital in southern Finland (a region with 208 000 inhabitants) was performed.
Results: The non-response-adjusted prevalence (Drane's linear method) of doctor-diagnosed asthma was 4.4% (95% CI: 3.3-5.5%) and of COPD 3.7% (95% CI: 2.7-4.8%). The prevalence of allergic rhinitis was 37.3% (95% CI: 33.3-41.2%), and of overall aspirin intolerance 5.7% (95% CI: 4.4-7.1%). The observed prevalence of aspirin intolerance causing shortness of breath or attacks of asthma was 1.2% and it was higher in patients with doctor-diagnosed asthma than without (8.8% versus 0.8%, relative risk [RR] = 11.4, P < 0.0001), and higher in those with allergic-like rhinitis than without (2.6% versus 0.3%, RR = 7.7, P < 0.0001). The prevalence of nasal polyposis was 4.3% (95% CI : 2.8-5.8%).
Conclusions: The current prevalence of doctor-diagnosed asthma among adults is 4.4%, and allergic rhinitis, nasal polyposis and aspirin intolerance are associated with an increased risk of asthma. There is also association between aspirin-induced asthma and allergic-like rhinitis.
Similar articles
- [Aspirin hypersensitivity: characteristics and diagnostic approach].
Baudrand H, Zaouche S, Dubost R, Carsin A, Chatte G, Freymond N, Piperno D, Dubreuil C, Froehlich P, Pacheco Y, Devouassoux G. Baudrand H, et al. Rev Mal Respir. 2015 Mar;32(3):221-8. doi: 10.1016/j.rmr.2014.04.100. Epub 2014 Jun 25. Rev Mal Respir. 2015. PMID: 25847199 French. - Nasal polyps in patients with rhinitis and asthma.
Grigoreas C, Vourdas D, Petalas K, Simeonidis G, Demeroutis I, Tsioulos T. Grigoreas C, et al. Allergy Asthma Proc. 2002 May-Jun;23(3):169-74. Allergy Asthma Proc. 2002. PMID: 12125503 - Influence of allergy on the symptoms and treatment of nasal polyposis.
Bonfils P, Avan P, Malinvaud D. Bonfils P, et al. Acta Otolaryngol. 2006 Aug;126(8):839-44. doi: 10.1080/00016480500504226. Acta Otolaryngol. 2006. PMID: 16846927 - [Polyposis of the nasal sinuses. Epidemiology and clinical aspects of 350 cases. Treatment and results with a follow-up over 5 years on 93 cases].
Braun JJ, Haas F, Conraux C. Braun JJ, et al. Ann Otolaryngol Chir Cervicofac. 1992;109(4):189-99. Ann Otolaryngol Chir Cervicofac. 1992. PMID: 1485748 Review. French. - [Hypersensitivity to acetylsalicylic acid].
Wojtczak A, Skrętkowicz J. Wojtczak A, et al. Wiad Lek. 2015;68(2):193-7. Wiad Lek. 2015. PMID: 26181156 Review. Polish.
Cited by
- Aspirin Hypersensitivity in Patients with Coronary Artery Disease: An Updated Review and Practical Recommendations.
Cappannoli L, Colantuono S, Animati FM, Fracassi F, Galli M, Aurigemma C, Romagnoli E, Montone RA, Lunardi M, Paraggio L, Ierardi C, Baglivo I, Caruso C, Trani C, Burzotta F. Cappannoli L, et al. Biomolecules. 2024 Oct 19;14(10):1329. doi: 10.3390/biom14101329. Biomolecules. 2024. PMID: 39456262 Free PMC article. Review. - When the Nose Meets the Lab: Histopathological Analysis in Chronic Rhinosinusitis with Nasal Polyps for Routine Clinical Practice.
Alobid I, Armengot-Carceller M, Pinilla Urraca M, Maza-Solano J, González Guijarro I, Umbria Jiménez S, San Miguel Fraile P, Mullol J. Alobid I, et al. Curr Allergy Asthma Rep. 2024 Dec;24(12):657-665. doi: 10.1007/s11882-024-01180-8. Epub 2024 Oct 7. Curr Allergy Asthma Rep. 2024. PMID: 39373848 Free PMC article. Review. - Multi-Disciplinary Expert Perspective on the Management of Type 2 Inflammation-Driven Severe CRSwNP: A Brief Overview of Pathophysiology and Recent Clinical Insights.
Toppila-Salmi S, Bjermer L, Cardell LO, Cervin A, Heinikari T, Lehtimäki L, Lundberg M, Richter JC, Sillanpää S. Toppila-Salmi S, et al. J Asthma Allergy. 2024 May 9;17:431-439. doi: 10.2147/JAA.S447093. eCollection 2024. J Asthma Allergy. 2024. PMID: 38745838 Free PMC article. - Deep learning algorithm for the automated detection and classification of nasal cavity mass in nasal endoscopic images.
Kwon KW, Park SH, Lee DH, Kim DY, Park IH, Cho HJ, Kim JS, Kim JY, Hong SD, Kim SA, Yoo SH, Park SK, Heo SJ, Kim SH, Won TB, Choi WR, Kim YM, Kim YW, Kim JY, Kwon JH, Yu MS. Kwon KW, et al. PLoS One. 2024 Mar 13;19(3):e0297536. doi: 10.1371/journal.pone.0297536. eCollection 2024. PLoS One. 2024. PMID: 38478548 Free PMC article. - [Does aspirin therapy after desensitization still have a role in treatment of chronic rhinosinusitis with nasal polyposis in the era of biologics?].
Klimek F, Förster-Ruhrmann U, Hagemann J, Cuevas M, Gröger M, Klimek L. Klimek F, et al. HNO. 2024 Jul;72(7):484-493. doi: 10.1007/s00106-024-01431-0. Epub 2024 Feb 26. HNO. 2024. PMID: 38409556 Review. German.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical